Literature DB >> 19223783

Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia.

Sarita Shah1, Meaza Demissie, Lauren Lambert, Jelaludin Ahmed, Sileshi Leulseged, Tekeste Kebede, Zenebe Melaku, Yohannes Mengistu, Eshetu Lemma, Charles D Wells, Tadesse Wuhib, Lisa J Nelson.   

Abstract

OBJECTIVE: To evaluate commonly available screening tests for pulmonary tuberculosis (TB), using sputum bacteriology as a gold standard, in HIV-infected persons attending an urban voluntary counseling and testing clinic in Addis Ababa, Ethiopia.
DESIGN: Prospective enrollment of HIV-infected persons, all of whom underwent TB screening, regardless of symptoms, with: (1) symptom screening and physical examination, (2) 3 sputum specimens for smear microscopy, and (3) chest radiograph. One sputum was also sent for concentrated smear microscopy and mycobacterial culture. Chest radiographs were reviewed by 2 independent radiologists. A confirmed TB diagnosis was defined as 1 positive sputum smear and/or 1 positive sputum culture.
RESULTS: We enrolled 438 HIV-infected persons: 265 (61%) females, median age 34 years (range: 18-65), median CD4 cell count 181 cells per cubic millimeter (range: 2-1185). Overall, 32 (7%) persons were diagnosed with TB, of whom 5 (16%) were asymptomatic but culture-confirmed TB cases. Screening for cough >2 weeks would have detected only 12 (38%) confirmed TB cases; screening for cough or fever, of any duration, would have detected 24 (75%) cases, with specificity of 64%. Negative predictive value of screening for these 2 symptoms was 97%. Simulation of the current Ethiopian national guidelines had a sensitivity of 63% and specificity of 83% for diagnosing TB disease among study patients.
CONCLUSIONS: Traditional symptom screening is insufficient for detecting TB disease among HIV-infected persons but may serve to exclude TB disease. More sensitive, rapid, and low-cost diagnostic tests are needed to meet the demand of resource-limited settings.

Entities:  

Mesh:

Year:  2009        PMID: 19223783     DOI: 10.1097/QAI.0b013e318196761c

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  44 in total

1.  'Cough officer' nurses in a general medical clinic successfully detect drug-susceptible and -resistant tuberculosis.

Authors:  S V Shenoi; R P Brooks; K Catterick; A P Moll; G H Friedland
Journal:  Public Health Action       Date:  2013-03-21

2.  Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays.

Authors:  A Steiner; C Mangu; J van den Hombergh; H van Deutekom; B van Ginneken; P Clowes; F Mhimbira; S Mfinanga; A Rachow; K Reither; M Hoelscher
Journal:  Public Health Action       Date:  2015-12-21

3.  Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia.

Authors:  S Zaeh; R Kempker; E Stenehjem; H M Blumberg; O Temesgen; I Ofotokun; A Tenna
Journal:  Int J Tuberc Lung Dis       Date:  2013-11       Impact factor: 2.373

4.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

Review 5.  Improving the diagnosis of tuberculosis: From QuantiFERON to new techniques to diagnose tuberculosis infections.

Authors:  Amy Y Vittor; Joseph M Garland; David Schlossberg
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

Review 6.  Tuberculosis as part of the natural history of HIV infection in developing countries.

Authors:  Gabriel Chamie; Annie Luetkemeyer; Edwin Charlebois; Diane V Havlir
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

7.  Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.

Authors:  Ingrid V Bassett; Bingxia Wang; Senica Chetty; Janet Giddy; Elena Losina; Matilda Mazibuko; Benjamin Bearnot; Jenny Allen; Rochelle P Walensky; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2010-10-01       Impact factor: 9.079

8.  Active tuberculosis case finding and detection of drug resistance among HIV-infected patients: A cross-sectional study in a TB endemic area, Gondar, Northwest Ethiopia.

Authors:  Martha Alemayehu; Baye Gelaw; Ebba Abate; Liya Wassie; Yeshambel Belyhun; Shiferaw Bekele; Russell R Kempker; Henry M Blumberg; Abraham Aseffa
Journal:  Int J Mycobacteriol       Date:  2014-03-24

9.  Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Authors:  J Lucian Davis; William Worodria; Harriet Kisembo; John Z Metcalfe; Adithya Cattamanchi; Michael Kawooya; Rachel Kyeyune; Saskia den Boon; Krista Powell; Richard Okello; Samuel Yoo; Laurence Huang
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.

Authors:  Tyler Smith; Taraz Samandari; Taiwo Abimbola; Barbara Marston; Nalinee Sangrujee
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.